UK markets closed

IDEAYA Biosciences, Inc. (IDYA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.18+0.69 (+1.66%)
At close: 04:00PM EDT
42.18 0.00 (0.00%)
After hours: 04:03PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-112,961
-112,961
-58,655
-49,762
-34,495
Depreciation & amortisation
4,008
4,008
3,515
3,032
1,381
Stock-based compensation
18,489
18,489
11,629
8,237
3,609
Change in working capital
-13,207
-13,207
-42,969
-19,120
84,406
Accounts receivable
193
193
892
774
-1,877
Accounts payable
2,635
2,635
1,864
1,166
225
Other working capital
-117,592
-117,592
-90,618
-58,423
54,970
Net cash provided by operating activities
-115,224
-115,224
-87,175
-55,779
55,463
Cash flows from investing activities
Investments in property, plant and equipment
-2,368
-2,368
-3,443
-2,644
-493
Purchases of investments
-595,980
-595,980
-255,808
-314,996
-242,314
Sales/maturities of investments
439,892
439,892
225,847
247,974
96,564
Net cash used for investing activities
-158,456
-158,456
-33,404
-69,666
-146,243
Cash flows from financing activities
Common stock issued
309,763
309,763
94,962
143,253
127,234
Net cash used provided by (used for) financing activities
362,717
362,717
97,165
145,454
128,750
Net change in cash
89,037
89,037
-23,414
20,009
37,970
Cash at beginning of period
68,738
68,738
92,152
72,143
34,173
Cash at end of period
157,775
157,775
68,738
92,152
72,143
Free cash flow
Operating cash flow
-115,224
-115,224
-87,175
-55,779
55,463
Capital expenditure
-2,368
-2,368
-3,443
-2,644
-493
Free cash flow
-117,592
-117,592
-90,618
-58,423
54,970